Paraneoplastic autoimmunity in thymus tumors

Developmental Immunology

Volumn 6, Issue 1-2, 1998, Pages 129-140

  Marx, Alexander ^a   Schultz, Anja ^a   Wilisch, Annette ^a   Helmreich, Markus ^a   Nenninger, Regina ^a   Müller Hermelink, Hans Konrad ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Acetylcholine receptor; Neurofilaments; T cells; Thymoma; Titin

Indexed keywords

AUTOANTIBODY; CHOLINERGIC RECEPTOR;

AUTOIMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRUCTURE; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMOMA;

EID: 0031656539     PISSN: 10446672     EISSN: None     Source Type: Journal    
DOI: 10.1155/1998/49484     Document Type: Conference Paper

References (39)

1. Aarli J.A., Stefansson K., Marton L.S.G. and Wollmann R.L. (1990). Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin. Exp. Immunol., 82: 284-288.
2. Andonopoulos A.P., Papthanasopoulos P.G., Karatza C. and Angelopoulos J. (1991). Sarcoidosis in a patient with myasthenia gravis. Case report and review of the literature. Clin. Rheumatol. 10: 323-325.
3. Ashton-Rickardt P.G. and Tonegawa S. (1994). A differential-avidity model for T cell selection. Immunol. Today 15: 362-366.
4. Drachman D.B. (1994). Myasthenia gravis. N. Engl. J. Med. 330: 1797-1810.
5. Gattenlöhner S., Brabletz T., Schultz A., Marx A., Müller-Hermelink H.K. and Kirchner Th. (1994). Cloning of a cDNA coding for the acetylcholine receptor alpha-subunit from a thymoma associated with myasthenia gravis. Thymus 23: 103-113.
6. Gautel M., Lakey A., Barlow D.P., Holmes Z., Scales S., Leonard K., Labeit S., Mygland A., Gilhus N.E. and Aarli J.A. (1993). Titin antibodies in myasthenia gravis: Identification of a major immunogenic-region of titin. Neurology 43: 1581-1585.
7. Geuder K.I., Marx A., Witzemann V., Schalke B., Kirchner Th. and Müller-Hermelink H.K. (1992). Genomic organization and lack of transcription of the nicotinic receptor subunit geneses in myasthenia gravis associated thymoma. Lab. Invest. 66: 452-458.
8. Gilhus N.E., Willcox N., Harcourt G., Nagvekar N., Beeson D., Vincent A. and Newsom-Davis J. (1995). Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. J. Neuroimmunol. 56: 65-76.
9. Hara Y., Hayashi K., Ohta K., Itoh N. and Ohta M. (1993). Nicotinic acethylcholine receptor mRNAs in myasthenia thymuses. Association with intrathymic pathogenesis of myasthenia gravis. Biochem. Biophys. Res. Commun. 194: 1269-1275.
10. Hogguist K.A., Jameson S.C., Heath W.R., Howard J.L., Bevan M.J. and Carbone F.R. (1994). T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
11. Kirchner Th., Hoppe F., Schalke B. and Müller-Hermelink H.K. (1988a). Microenvironment of thymic myoid cells in myasthenia gravis. Virchows Archiv. B. Cell. Pathol. 54: 295-302.
12. Kirchner Th., Schalke B., Buchwald J., Ritter M., Marx A. and Müller-Hermelink H.K. (1992). Well-differentiated thymic carcinoma. An organotypic low-grade carcinoma with relationship to cortical thymoma. Amer. J. Surg. Pathol. 16: 1153-1169.
13. Kirchner T., Tzartos S., Hoppe F., Schalke B., Wekerle H. and Müller-Hermelink H.K. (1988b). Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors. Amer. J. Pathol. 130: 268-280.
14. Lehrmann P.V., Sercarz E.E., Firsthuber T., Dayan C.M. and Gammon G. (1993). Determinant spreading and the dynamics of the autoimmune T cell repertoire. Immunol. Today 14: 203-208.
15. Marx A., Geuder K.I., Schoepfer R., Tzartos S., Kristoffersson U., Schalke B., Kirchner Th. and Müller-Hermelink H.K. (1991). Analysis of the acetyicholine receptor epitope-bearing protein p153 in thymomas favours "false-positive T cell selection" as a mechanism of paraneoplastic myasthenia gravis. In Lymphatic Tissues and In Vivo Immune Responses (New York: Marcel Decker), pp. 577-583.
16. Marx A., Kirchner Th., Greiner A., Müller-Hermelink H.K., Schalke B. and Osbom M. (1992). Neurofilament epitopes in thymoma and antiaxonal autoantibodies in myasthenia gravis. Lancet 339: 707-708.
17. Marx A., O'Connor R., Geuder K.I., Hoppe F., Schalke B., Tzartos S., Kalies I., Kirchner Th. and Müller-Hermelink H. K. (1990). Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab. Invest. 62: 279-286.
18. Marx A., Schömig D., Schultz A., Gattenlöhner S., Jung A., Kirchner T., Melms A. and Müller-Hermelink H.K. (1994). Distribution of molecules mediating thymocyte-stroma interactions in human thymus, thymitis and thymic epithelial tumors. Thymus 23: 83-93.
19. Marx A., Schultz A., Wilisch A., Nenninger R. and Müller-Hermelink H.K. (1996a). Myasthenia gravis. Verhandl. Dtsch. Ges. Pathol. 80: 116-120.
20. Marx A., Wilisch A., Schultz A., Greiner A., Magi B., Pallini V., Schalke B., Toyka K.V., Kirchner Th. and Müller-Hermelink H.K. (1996b). Expression of neurofilaments and of a titin epitope in thymic epithelial tumors. Amer. J. Pathol. 148: 1839-1850.
21. Melms A. Malcherek G., Gern U., Wiethölter H., Müller C.A., Schoepfer R. and Lindstrom J. (1992). T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: Hoeterogeneity of antigenic sites on the alpha-subunit. Ann. Neurol. 31: 311-318.
22. Müller-Hermelink H.K., Marx A. and Kirchner T. (1996). Thymus and mediastinum. In Anerson's Pathology, 10th ed., Damjanov I. and Lindner J., Eds. (St. Louis: Mosby Year-Book Inc.), pp. 1218-1255.
23. Müller-Hermelink H.K., Wilisch A., Schultz A. and Marx A. (1997). Characterization of the human thymic microenvironment: Lymphoepithelial interaction in normal thymus and thymoma. Arch. Histol. Cytol. 60: 9-28.
24. Mygland A., Aarli J.A., Matre R. and Gilhus N.E. (1994). Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. J. Neurol. Neurosurg. Psych. 75: 843-846.
25. Mygland A., Kuwajima G., Mikoshiba K., Aarli J.A. and Gilhus N.E. (1997). Thymomas express ryanodine receptor epitopes. In Epithelial Tumors of the Thymus (Pathology, Biology, Treatment), Marx A. and Müller-Hermelink H.K., Eds., (London: Plenum Press), pp.
26. Nenninger R., Schultz A., Wilisch A., Müller-Hermelink H.K. and Marx A. (1996). Abnormal T cell maturation in myasthenia gravis-associated thymomas. Verh. Dtsch. Ges. Path. 80: 256-260.
27. Nix W.A., Große-Höötmann H., Kirchner T. and Marx A. (1997). Management of thymectomized myasthenic patients. In Epithelial Tumors of the Thymus (Pathology, Biology, Treatment), Marx A. and Müller-Hermelink H.K., Eds., (London: Plenum Press), pp. 351-356.
28. Rosai J., Ed. (1996). Mediastinum. In Ackermann's Surgical Pathology, 8th ed., (St. Louis: Mosby Year-Book Inc.), pp. 1:435-491.
29. Schalke B.C.G., Schmitt I., Marx A., Toyka K.V. and Müller-Hermelink H.K. (1997). Long-term prognosis of patients with thymoma-associated myasthenia gravis. In Epithelial Tumors of the Thymus (Pathology, Biology, Treatment), Marx A. and Müller-Hermelink H.K., eds. (London: Plenum Press), pp. 329-335.
30. Siara J., Rüdel R. and Marx A. (1991). Absence of acetylcholine-induced current in epithelial cells from thymus glands and thymomas of myasthenia gravis patients. Neurology 41: 128-131.
31. Sommer N., Willcox N., Harcourt G.C. and Newsom-Davis J. (1990). Myasthenic thymus and thymoma are selectively enriched in acetylcholine receptor-reactive T cells. Ann. Neurol. 28: 312-319.
32. Somnier F.E. (1994). Exacerbation of myasthenia gravis after removal of thymomas. Acta Neurol. Scand. 90: 56-66.
33. Surh C.D., Sprent J. and Webb S.R. (1993). Exclusion of circulating T cells from the thymus does not apply in the neonatal period. J. Exp. Med. 177: 379-385.
34. Vincent A. (1994). Aetiological factors in development of myasthenia gravis. Adv. Neuroimmunol. 4: 355-371.
35. Vincent A., Roberts M., Willison H., Lang B. and Newsom-Davis J. (1995). Autoantibodies, neurotoxins and the nervous system. J. Physiol. Paris 89: 129-136.
36. Vincent A. and Willcox N. (1994). Characterization of AChR specific T cells in myasthenia gravis. Immunol. Today 15: 41-42.
37. Wilisch A., Schultz A., Jung A., Schalke B., Toyka K.V., Pallini V., Müller-Hermelink H.K. and Marx A. (1997). Titin epitope in thymoma. In Epithelial Tumors of the Thymus (Pathology, Biology, Treatment), Marx A. and Müller-Hermelink H.K., eds. (London: Plenum Press), pp. 221-227.
38. Willcox N. (1993). Myasthenia gravis. Cur. Opin. Immunol. 5: 910-917.
39. Williams C.L., Hay J.E., Hiatt T.W. and Lennon V.A. (1992). Paraneoplastic IgG Striational Autoantibodies Produced by Clonal Thymic B Cells and in Serum of Patients with Myasthenia Gravis and Thymoma React with Titin. Lab. Invest. 66: 331-336.